key: cord-1041193-1ncrl2fn
authors: Bradley, Declan T.; Murphy, Siobhán; McWilliams, Paul; Arnold, Sarah; Lavery, Siobhán; Murphy, Joanne; de Lusignan, Simon; Hobbs, Richard; Tsang, Ruby S.M.; Akbari, Ashley; Torabi, Fatemeh; Beggs, Jillian; Chuter, Antony; Shi, Ting; Vasileiou, Eleftheria; Robertson, Chris; Sheikh, Aziz; Reid, Heather; O’Reilly, Dermot
title: Investigating the association between COVID-19 vaccination and care home outbreak frequency and duration
date: 2021-12-18
journal: Public Health
DOI: 10.1016/j.puhe.2021.12.010
sha: f05aaf6956c839b63653715570fbf8218fb66193
doc_id: 1041193
cord_uid: 1ncrl2fn

Objectives At the end of 2020, many countries commenced a vaccination programme against SARS-CoV-2. Public health authorities aim to prevent, and interrupt, outbreaks of infectious disease in social care settings. We aimed to investigate the association between the introduction of the vaccination programme and the frequency and duration of COVID-19 outbreaks in Northern Ireland (NI). Study Design We undertook an ecological study using routinely available national data. Methods We used Poisson regression to measure the relationship between the number of RT-PCR confirmed COVID-19 outbreaks in care homes and, as a measure of community COVID-19 prevalence, the Office for National Statistics COVID-19 Infection Survey estimated number of people testing positive for COVID-19 in NI. We estimated the change in this relationship and estimated the expected number of care home outbreaks in the absence of the vaccination programme. A Cox proportional hazards model estimated the hazard ratio of a confirmed COVID-19 care home outbreak closure. Results Care home outbreaks reduced by two-thirds compared to expected following the introduction of the vaccination programme, from a projected 1,625 COVID-19 outbreaks (95% prediction interval 1,553 – 1,694) between 7 December 2020 and 28 October 2021 to an observed 501. We estimated an adjusted hazard ratio of 2.53 of the outbreak closure assuming a 21-day lag for immunity. Conclusions These findings describe the association of the vaccination with a reduction in outbreak frequency and duration across NI care homes. This indicates probable reduced harm and disruption from COVID-19 in social care settings following vaccination. Future research using individual level data from care home residents will be needed to investigate effectiveness of the vaccines and the duration of their effects.

Objectives 2 At the end of 2020, many countries commenced a vaccination programme against 3 SARS-CoV-2. Public health authorities aim to prevent, and interrupt, outbreaks of 4 infectious disease in social care settings. We aimed to investigate the association 5 between the introduction of the vaccination programme and the frequency and 6 duration of COVID-19 outbreaks in Northern Ireland (NI). 7

We undertook an ecological study using routinely available national data. 9

We used Poisson regression to measure the relationship between the number of PCR confirmed COVID-19 outbreaks in care homes and, as a measure of 12 community COVID-19 prevalence, the Office for National Statistics COVID-19 13 Infection Survey estimated number of people testing positive for COVID-19 in NI. We 14 estimated the change in this relationship and estimated the expected number of care 15 home outbreaks in the absence of the vaccination programme. A Cox proportional 16 hazards model estimated the hazard ratio of a confirmed COVID-19 care home 17 outbreak closure. 18

Care home outbreaks reduced by two-thirds compared to expected following the 20 introduction of the vaccination programme, from a projected 1,625 COVID-19 21 outbreaks (95% prediction interval 1,553 -1,694) between 7 December 2020 and 28 22

October 2021 to an observed 501. We estimated an adjusted hazard ratio of 2.53 of 23 the outbreak closure assuming a 21-day lag for immunity. 24

These findings describe the association of the vaccination with a reduction in 26 outbreak frequency and duration across NI care homes. This indicates probable 27 reduced harm and disruption from COVID-19 in social care settings following 28 vaccination. Future research using individual level data from care home residents will 29 be needed to investigate effectiveness of the vaccines and the duration of their 30 effects. 31 Introduction 1 COVID-19 has caused a disproportionately high number of deaths among the 2 residents of care homes in the UK 1 ; an experience shared by other countries. 2-5 In 3

Northern Ireland (NI), there have been 1,127 COVID-19-related deaths among care 4 home residents by the week ending 5 November 2021 6 . Care home residents may 5 be at high risk of exposure to SARS-CoV-2 because of outbreaks in these closed 6 settings and greater vulnerability to severe outcomes because of age and 7 comorbidities. 2,3 A range of factors contribute to the risk, size and duration of 8 outbreaks in care homes, including the background community incidence of 9

infection, the prevalence of infection in care home staff, care home size, the use of 10 bank and agency staff, regional variation and whether homes provided sick pay to 11 their staff. 5, 7 29  of the care home vaccination programme with a 21-day interval between doses, as  30  most implementation occurred before the change in policy to a 12-week dosing  31 interval, which was announced on 31 December 2020. In advance of individual-level 32 data being available, we sought to investigate the association between the COVID-33

19 vaccination programme on COVID-19 outbreak frequency and duration. The 34 vaccination programme was introduced at a time when there were changes in non-35 pharmaceutical interventions (including a period of 'lockdown') in NI, which were 36 associated with considerable changes in the growth of the epidemic. Investigation of 37 the association between the vaccination programme and changes in COVID-19 38 outcomes therefore needed to use methods that would not be confounded by this 39 changing context. The aim of our study was to assess the association of the COVID- 

This study was undertaken using routine data, accessed under pre-existing 3 information governance arrangements, for the purpose of health protection 4 surveillance, and for health and social care service delivery and evaluation. 5

Research ethics approval was not required. 6

There were 480 operational care homes in NI on 18 November 2021 (Table 1) . 10 8

Care home occupancy is dynamic over time, though occupancy is high. The majority 9

of homes were independent, with some were directly operated by HSC Trusts. 10 

Two or more cases in a facility which meet the case definition of a possible or 26 confirmed case of COVID-19, within a 14-day period among either residents or staff 27 in the care home 28

Identification of two or more confirmed COVID-19 cases (both symptomatic and 30 asymptomatic detection), among either residents or staff in the care home, within a 31 14-day period. 32

Closed outbreaks 33 J o u r n a l P r e -p r o o f An outbreak was closed when there have been no new cases for 14 days after 1 symptom onset of most recent case and a terminal clean was complete. 2

Daily returns from care homes to the Regulation and Quality Improvement Authority 4

All care homes in NI participated in a monitoring scheme through which they 5 submitted daily aggregate data to the Regulation and Quality Improvement Authority 6 (RQIA). Summary information from these reports was made available to us in the 7

Public Health Agency (PHA). The submissions from each care home for the previous 8 calendar month, along with the maximum number of staff employed and number of 9 beds occupied during that month, were used to estimate of the number of staff and 10 residents for each care home. 11

Care home outbreak surveillance 12

The PHA health protection (HP) team was notified by care homes of cases of 13 COVID-19. An outbreak was declared when two or more cases among care home 14 residents or staff in a facility meet the case definition of a possible or confirmed case 15 of COVID-19 within a 14-day period, according to the definitions above. 11 Once an 16 outbreak was notified information was entered into the management information 17 system, HP Zone. Data was extracted from HP Zone by the HP surveillance team, 18

cleaned and entered into a database. 19

The 

We used the ONS CIS estimated number of people testing positive for COVID-19 as 1 a measure of the severity of the epidemic in the general population. We explored the 2 relationship between this measure and the weekly frequency of new PCR-confirmed 3 COVID-19 care home outbreaks by plotting these in a scatter plot. We used ccf in R 4 v 4.0.2 for the cross-correlation function to assess for a time lag between the 5 variables, and applied the time lag associated with the maximum correlation before 6

fitting a Poisson regression model using glm in R v 4.0.2. We chose a Poisson model 7 because the dependent variable was a count of events, and the low value daily 8 counts of care home outbreaks did not meet the assumptions required for linear 9 regression. We divided the time series into a pre-vaccination period, before 7 10

December 2020, a 'washout' period from 7 December 2020 to 28 February 2021 11

inclusive, and a post-vaccination period from 1 March 2021 to 3 November 2021. 12

The majority of care homes had first vaccinations delivered during December 2020 13

( Figure S1 ). Staff and residents were offered vaccination at the same time. Those 14 that were in an outbreak at the time vaccination was due were deferred. conditions of the pre-vaccination time period had continued. The total projected 33 number of outbreaks for the time and its confidence limits were estimated by 1,000 34 simulations that used rpois for random daily projections, summing the projected 35 number of outbreaks in the time period for each simulation, and taking the median 36 and the 2.5% and 97.5% quantiles of the simulated total outbreak counts. 37

A Cox proportional hazards model was used to produce the hazard ratios (HR) and 39 95% confidence intervals (CIs) to measure the hazard ratio for a care home COVID-40 19 outbreak being declared over. The likelihood of an outbreak is known to be 41 directly related to care home size. 5, 13 For this analysis, residents in each home 42 ranged from one to 100 and staff from three to 280. Community prevalence of 43 COVID-19 affects prevalence of the virus in care home settings. 13 To adjust for this, 44 the rolling 7-day prevalence of COVID-19 at Super Output Level (SOA) and care 45 home size were adjusted for in the model. 46

Each of the homes with a reported outbreak represented a case with the time since 47 first visit at which COVID-19 vaccination was administered to staff and/or residents 48 as the exposure and duration of outbreak as the outcome. The exposure time was 1 lagged by 21 days from the first visit to vaccinate the staff and residents to account 2 for the lead time from vaccination to immunity. The 21-day lag period was chosen as 3 a time point by which vaccine would be in effect (69% vaccine effectiveness at 14- 20 4 days and 79% at 21-28 days after first dose in people aged 80 years or older). 14 A 5

Kaplan Meier plot was produced showing 'survival' of outbreaks by care home 6 vaccination status. The time lag was altered to 14, 28 and 35 days as a sensitivity 7 analysis for the Cox regression (which includes the time period of the second dose of 8 vaccine for most care homes). We considered only the effect of time from first 9 vaccine (rather than whether there was a second vaccine visit) as we had no way of 10 separating any changes associated with the passage of time from the first dose from 11 any change associated with a second dose. Most homes received their second visit 12 at 21 days, and the presence of an outbreak was a potential reason for the second 13 vaccine being delayed. 14 shown separately (Figures S3 and S4) . We used a Cox proportional hazards model to investigate whether care homes that 5 had been offered the vaccination had a higher likelihood of outbreak closure than 6 those homes that had not reached that immunity threshold. Between 7 December 7 2020 to 8 April 2021 there were 179 confirmed COVID-19 outbreaks in care homes 8

following the first vaccination, 175 of which had ended at the time of analysis. 9

Median outbreak duration was 29 days from notification to closure (Table S1) The findings indicate that vaccinated homes had a significantly higher hazard ratio of 16 experiencing outbreak closure over time than homes in which the vaccination 17 programme had not yet been implemented (Table 2) . These findings remain after 1 adjusting for care home size and measures of community prevalence of COVID-19. 2

The daily hazard ratios analysis illustrating the effect of using different time lags for 3 immunity from vaccination shows the effect days post-vaccination the likelihood of 4 outbreak closure increases and appears to stabilise by day 28 ( Figure S5 ). 5 6 size and community prevalence. 10

The COVID-19 pandemic has had a severe impact on care home residents and staff 12

worldwide. Consequently, residents and staff were amongst the first groups to be 13 offered vaccination. Our findings suggest that the introduction of the COVID-19 14 vaccination programme in NI was associated with a two-thirds reduction in the 15 frequency of confirmed COVID-19 outbreaks in care homes compared to the 16 expected number. This relative effect was the same in nursing and residential 17

homes. We showed that the outbreak duration was shorter in homes where the 18 vaccine had been delivered. These findings provide evidence that the vaccination 19

programme had a positive impact on outbreaks in care homes. 20

Outbreaks occurred in the post vaccination period and there are many potential 21 explanations for this. Not all residents and staff will have been vaccinated, and not all 22 those vaccinated will have been fully protected against infection. Furthermore, the 23 care home population is dynamic, with new residents arriving, many of whom would 24

not have been vaccinated. The workforce is also dynamic, and staff may frequently 25 move between care homes and not all were vaccinated. jurisdictions can be expected to observe these developments with interest. 34

The findings of this study should be interpreted in the context of its methodological 35 limitations. We did not have access to individual vaccination status at the time of 36 J o u r n a l P r e -p r o o f writing and future work on individual level data will be needed to validate our 1 findings. We chose not to use aggregate counts of the number of individuals 2 vaccinated within homes, or the number of cases within outbreaks. Though these 3 aggregate data were reported and collected, we were advised by PHA that these 4 data were not suitable for statistical analysis due to variation in the completeness 5 and quality of these between and within homes, and over time. Therefore, we used 6 the dates of events, which were considered more robust. Outbreak dates were 7 recorded by PHA. We did not attempt to account for the potentially complex 8

interactions between past outbreaks, delays to vaccination, and the resulting 9 synergistic effects of vaccination on a background of recent infection, which would 10 reduce the chance of future outbreaks. This warrants deeper exploration in future. 11

Individual-level data would enable linkage across a range of administrative datasets 12

to assess the effectiveness of the vaccination programme against a range of 13

outcomes. Reliable information about whether individuals are in a specific care home 14 is elusive in administrative information systems and the challenges of accurately 15 identifying and following these individuals have been well-documented. [17] [18] The 16

pandemic has also highlighted how investment in development of minimum dataset 17

for care home residents is needed to understand the health needs and outcomes of 18 this vulnerable population. The association between community prevalence and care 19 home outbreaks measured in the pre-vaccination status might be sensitive to the fact 20 that the ONS CIS data were not available for a period of very low community 21

prevalence. Though we did not aim to measure the incremental benefit of the second 22

dose that was delivered after a 21-day interval, there was no obvious increase at 28 23 or 35 days in sensitivity analyses, or in the estimates of hazard ratio with time 24

beyond 21 days in Figure S5 . This might be explained by the wide confidence limits 25 (our study was not designed or powered to directly compare the effect of the second 26 to first doses), that infection prevention and control measures in place during this 27 period may have been sufficiently robust to mask the incremental benefit of the 28 second dose, or that the benefit of the first dose may give a level of protection due to 29 network effects that, at a group level, makes the effect of the second dose less 30 evident. 31

By the end of 2020, the UK Medicines and Healthcare products Regulatory Agency 32 (MHRA) approved two vaccines, Pfizer-BioNTech and Oxford-AstraZeneca, for 33

administration. The speed with which these vaccines were available has been 34 unprecedented. In the UK, as of 1 December 2021, 116 million COVID-10 vaccines 35

have been administered. 19 Public Health England recently reported that a single 36 dose of the Pfizer vaccine was approximately 60-70% effective at preventing 37 symptomatic disease which increased to approximately 85-90% following two doses 38 in over 70-year-olds. 20 For those vaccinated who later developed COVID-19 there 39 was a 44% lower risk of hospitalisation and a 51% lower risk of death compared to 40 unvaccinated people. 20 In looking specifically at care home residents, a large UK 41 cohort study of 10,400 residents reported vaccine effectiveness estimates of 62% 42 against PCR-confirmed infection following first vaccination. 21 Furthermore, a recent 43 preliminary study suggests that a single dose of vaccine may be sufficient to obtain a 44 high level of S-protein IgG antibody in nursing home residents previously diagnosed 45

with COVID-19. 22 Collectively, these findings are encouraging and demonstrate the 46 success of the vaccination programme in the early stages in reducing outbreaks 47 across NI care homes. This evidences a significant degree of protection among a 48 vulnerable and at-risk population against the severe consequences of COVID-19. 49

Future research using individual level data and across longer periods post 1 vaccination will be needed to determine the magnitude and duration of this 2 protection. 3

Belfast and the Public Health Agency, NI; he is seconded to the NI Department of 5

Health. 

Mortality among Care Home 14 Residents in England during the first and second waves of the COVID-19 15 pandemic: an analysis of 4.3 million adults over the age of 65

COVID-19 related mortality and 18 spread of disease in long-term care: a living systematic review of 19 emerging evidence

Mortality associated with 21 COVID-19 outbreaks in care homes: Early International 22 Evidence

Excess mortality for care 25 home residents during the first 23 weeks of the COVID-19 pandemic in 26 England: a national cohort study

Evolution and effects of COVID-19 28 outbreaks in care homes: a population analysis in 189 care homes in one 29 geographical region of the UK

Second versus first 40 wave of COVID-19 deaths: shifts in age distribution and in nursing home 41 fatalities

Committee on Vaccination and Immunisation: advice on priority 1 groups for COVID-19 vaccination 2020

Public Health England 2020. COVID-19: epidemiological definitions of 9 outbreaks and clusters in particular settings

Office for National Statistics. Coronavirus (COVID-19) Infection Survey

Characteristics of US nursing 18 homes with COVID-19 cases

Interim findings from first-dose mass COVID-19 20 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national 21 prospective cohort study

Closing the UK care home data 32 gap-methodological challenges and solutions: Closing the UK care home 33 data gap

Early effectiveness of COVID-19 41 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus 42 vector vaccine on symptomatic disease, hospitalisations and mortality in 43 older adults in England

Infection in Residents of Long Term Care Facilities (VIVALDI Study)

MedRxiv 2021

Spike Antibody Levels of Nursing 7 Home Residents With or Without Prior COVID-19 3 Weeks After a Single 8 BNT162b2 Vaccine Dose